Alere Inc logo

Alere Inc - SERIES B

(Preferred)
NYSE:ALRPRB.PFD (USA)   3 % Conv Perp Pfd Shs Series -B-
$ 402.00 0 (0%) 09:42 AM EST
At Loss
P/B:
3.86
Volume:
5.01K
Avg Vol (2M):
13.48K
Volume:
5.01K
At Loss
Avg Vol (2M):
13.48K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for ALRPRB.PFD ( Alere Inc ) from 2008 to Jun 07 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Alere stock (ALRPRB.PFD) PE ratio as of Jun 07 2024 is 0. More Details

Alere Inc (ALRPRB.PFD) PE Ratio (TTM) Chart

To

Alere Inc (ALRPRB.PFD) PE Ratio (TTM) Historical Data

Total 0
  • 1
Alere PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data

Alere Inc (ALRPRB.PFD) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Alere Inc logo
Alere Inc
NAICS : 334516 SIC : 3826
ISIN : US01449J2042

Share Class Description:

ALRPRB.PFD: 3 % Conv Perp Pfd Shs Series -B-
Description
Alere, Inc. develops rapid point-of-care diagnostic devices in cardiology, infectious disease, toxicology, diabetes, oncology, and women's health. North America accounts for the largest portion of the firm's revenue (55%), followed by Europe (19%), Asia-Pacific (14%), and the rest of the world (12%). Alere's headquarters are in Waltham, Massachusetts.